Basic information Safety Supplier Related

Methyl Benzimidazole-5-carboxylate

Basic information Safety Supplier Related

Methyl Benzimidazole-5-carboxylate Basic information

Product Name:
Methyl Benzimidazole-5-carboxylate
Synonyms:
  • METHYL BENZIMIDAZOLE-5-CARBOXYLATE
  • METHYL 1H-BENZIMIDAZOLE-5-CARBOXYLATE
  • AKOS BBS-00000245
  • 1H-Benzimidazole-5-carboxylicacid,methylester(9CI)
  • methyl 1H-benzo[d]imidazole-5-carboxylate
  • 1H-Benzimidazole-5-carboxylic acid methyl ester
  • 1H-BenziMidazole-6-carboxylic Acid Methyl Ester
  • 5-(Methoxycarbonyl)benziMidazole
CAS:
26663-77-4
MF:
C9H8N2O2
MW:
176.17
Product Categories:
  • Aromatics
  • Heterocycles
  • Intermediates
  • Miscellaneous Reagents
  • BENZIMIDAZOLE
  • pharmacetical
  • Esters
  • Imidazoles & Benzimidazoles
  • Imidazoles & Benzimidazoles
Mol File:
26663-77-4.mol
More
Less

Methyl Benzimidazole-5-carboxylate Chemical Properties

Melting point:
139 °C
Boiling point:
416.2±18.0 °C(Predicted)
Density 
1.324±0.06 g/cm3(Predicted)
storage temp. 
Inert atmosphere,Room Temperature
form 
powder to crystal
pka
11.67±0.10(Predicted)
color 
White to Light yellow to Light orange
InChI
InChI=1S/C9H8N2O2/c1-13-9(12)6-2-3-7-8(4-6)11-5-10-7/h2-5H,1H3,(H,10,11)
InChIKey
WJHHIVYNOVTVGY-UHFFFAOYSA-N
SMILES
C1NC2=CC(C(OC)=O)=CC=C2N=1
More
Less

Safety Information

Hazard Codes 
Xi
Hazard Note 
Irritant
HS Code 
2933998090
More
Less

Methyl Benzimidazole-5-carboxylate Usage And Synthesis

Uses

Methyl Benzimidazole-5-carboxylate can be used as an intermediate used for the synthesis of a number of bioisosteric benzimidazoles as inhibitors of human cytosolic phospholipase A2α.

Synthesis

67-56-1

15788-16-6

26663-77-4

General procedure for the synthesis of methyl benzimidazole-5-carboxylate from methanol and 1H-benzimidazole-5-carboxylic acid: (a) Synthesis of methyl 1H-benzimidazole-5-carboxylate Thionyl chloride (0.135 mL, 1.85 mmol) was slowly added dropwise to a solution of 1H-benzimidazole-5-carboxylic acid (0.300 g, 1.85 mmol) in methanol (50.0 mL). The reaction mixture was refluxed for 12 hours. After completion of the reaction, the mixture was poured into saturated aqueous sodium bicarbonate solution and stirred thoroughly. The organic layer was separated and the aqueous layer was extracted with ethyl acetate (3 x 15 mL). The organic layers were combined, dried with anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to give a purple solid product in 90% yield. The crude product can be used in subsequent reactions without further purification. [MS (ES+) m/e 177 [M + H]+].

References

[1] Patent: WO2005/82901, 2005, A1. Location in patent: Page/Page column 91
[2] Patent: WO2013/26914, 2013, A1. Location in patent: Page/Page column 125
[3] Patent: WO2007/103755, 2007, A2. Location in patent: Page/Page column 111
[4] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 20, p. 2925 - 2930
[5] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 24, p. 3161 - 3164

Methyl Benzimidazole-5-carboxylateSupplier

Jiaxing Rich Biological Technology Co., Ltd. Gold
Tel
0573-11111111-1111 18969316891
Email
richmol@163.com
Henan Evonik Biotechnology Co. LTD Gold
Tel
15672878902
Email
hnyingchuang@163.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18